Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Bearish: Analysts Just Cut Their Moelis & Company (NYSE:MC) Revenue and EPS estimates

In This Article:

Today is shaping up negative for Moelis & Company (NYSE:MC) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds on the horizon.

Following the downgrade, the consensus from nine analysts covering Moelis is for revenues of US$1.1b in 2022, implying a painful 32% decline in sales compared to the last 12 months. Statutory earnings per share are anticipated to tumble 45% to US$3.09 in the same period. Prior to this update, the analysts had been forecasting revenues of US$1.2b and earnings per share (EPS) of US$4.09 in 2022. It looks like analyst sentiment has declined substantially, with a substantial drop in revenue estimates and a large cut to earnings per share numbers as well.

View our latest analysis for Moelis

earnings-and-revenue-growth
NYSE:MC Earnings and Revenue Growth July 19th 2022

The consensus price target fell 8.9% to US$42.43, with the weaker earnings outlook clearly leading analyst valuation estimates. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Moelis at US$53.00 per share, while the most bearish prices it at US$39.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that sales are expected to reverse, with a forecast 40% annualised revenue decline to the end of 2022. That is a notable change from historical growth of 17% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 5.4% per year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Moelis is expected to lag the wider industry.

The Bottom Line

The most important thing to take away is that analysts cut their earnings per share estimates, expecting a clear decline in business conditions. Regrettably, they also downgraded their revenue estimates, and the latest forecasts imply the business will grow sales slower than the wider market. Given the scope of the downgrades, it would not be a surprise to see the market become more wary of the business.